---
title: "Broach Lifecare Hospital Ltd (544231) — Share Price, Financials & Analysis"
symbol: "544231"
company: "Broach Lifecare Hospital Ltd"
canonical: "https://tapetide.com/stocks/544231"
isin: "INE0SFZ01018"
nse_symbol: "BROACHLIFECAREHOSPITALLTD"
bse_code: "544231"
sector: "Healthcare Services"
industry: "Hospitals"
market_cap_cr: 9.4
generated_at: "2026-09-13T18:26:45.203Z"
---

# Broach Lifecare Hospital Ltd (544231)

Canonical page: https://tapetide.com/stocks/544231

## Company

- **NSE Symbol:** BROACHLIFECAREHOSPITALLTD
- **BSE Code:** 544231
- **ISIN:** INE0SFZ01018
- **Sector:** Healthcare Services
- **Industry:** Hospitals
- **Macro Sector:** Healthcare
- **Stock Type:** EQUITY
- **Listed Since:** 2024-08-21
- **Face Value:** ₹10
- **F&O Eligible:** No
- **Website:** maplehospital.in

## About

Incorporated in 2023, Broach Lifecare Hospital Ltd is in the business of providing health
care services.[1]

## Latest Price

## Key Fundamentals

Observed at 2026-09-11T04:42:09.463850Z.

- **Market Cap:** ₹9.4 Cr
- **Classification:** SME
- **P/E (reported):** 110.7
- **Book Value:** ₹15.57
- **Price to Book:** 1
- **Dividend Yield:** 0%
- **ROE:** 5.72%
- **ROCE:** 7.89%
- **Debt to Equity:** 0
- **Revenue (yearly):** ₹5.99 Cr
- **Net Income:** ₹0.21 Cr
- **EBITDA:** ₹0.5 Cr
- **52-Week High:** ₹21.01
- **52-Week Low:** ₹12.01
- **RSI (14):** 22.71

## Key Insights

### Strengths

- Company has reduced debt.
- Company is almost debt free.
- Stock is trading at 1.00 times its book value

### Weaknesses

- Though the company is reporting repeated profits, it is not paying out dividend
- Company has a low return on equity of 6.45% over last 3 years.

## Growth Rates

| Metric | 1Y | 3Y | 5Y |
| --- | --- | --- | --- |
| cash flow growth | 81.27% | 34.74% | -112.81% |
| ebitda margin growth | -69.4% | -78.95% | -78.76% |
| net income growth | -58% | -16% | -58% |
| revenue growth | 87.19% | 49% | 11.35% |
| roce | -53.62% | 36.51% | 11.39% |
| roe | -55.17% | 8.29% | -10.63% |

## Financial Statements

### Quarterly Results

All figures in ₹ crore unless the row name says otherwise.

| Item | Sep 2023 | Mar 2024 | Sep 2024 | Mar 2025 | Sep 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- |
| Sales | 0.9 | 1.7 | 1.81 | 1.37 | 2.6 | 3.39 |
| Expenses | 0.52 | 1.05 | 1.16 | 1.2 | 2.08 | 3.4 |
| Operating Profit | 0.38 | 0.65 | 0.65 | 0.17 | 0.52 | -0.01 |
| OPM % | 42.22 | 38.24 | 35.91 | 12.41 | 20 | -0.29 |
| Other Income | 0 | 0 | 0 | 0.05 | 0.04 | 0 |
| Interest | 0 | 0 | 0 | 0.03 | 0.04 | 0 |
| Depreciation | 0.08 | 0.01 | 0.06 | 0.07 | 0.11 | 0.19 |
| Profit before tax | 0.3 | 0.64 | 0.59 | 0.12 | 0.41 | -0.2 |
| Tax % | 26.67 | 25 | 23.73 | 33.33 | 24.39 | 10 |
| Net Profit | 0.22 | 0.47 | 0.44 | 0.09 | 0.31 | -0.23 |
| EPS in Rs | 0.49 | 1.05 | 0.72 | 0.15 | 0.51 | -0.38 |

### Profit & Loss

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- |
| Sales | 3.39 | 1.82 | 2.61 | 3.12 | 5.99 |
| Expenses | 2.11 | 1.06 | 1.58 | 2.29 | 5.48 |
| Operating Profit | 1.28 | 0.76 | 1.03 | 0.83 | 0.51 |
| OPM % | 37.76 | 41.76 | 39.46 | 26.6 | 8.51 |
| Other Income | -0.24 | 0.1 | 0 | 0.05 | 0.04 |
| Interest | 0.09 | 0.27 | 0 | 0.03 | 0.04 |
| Depreciation | 0.33 | 0.41 | 0.09 | 0.13 | 0.3 |
| Profit before tax | 0.62 | 0.18 | 0.94 | 0.72 | 0.21 |
| Tax % | 25.81 | 27.78 | 25.53 | 25 | 57.14 |
| Net Profit | 0.46 | 0.14 | 0.7 | 0.54 | 0.09 |
| EPS in Rs | — | — | 1.57 | 0.89 | 0.15 |
| Dividend Payout % | 0 | 0 | 0 | 0 | 0 |

### Balance Sheet

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- |
| Equity Capital | 0.01 | 0.01 | 4.46 | 6.07 | 6.07 |
| Reserves | 2.24 | 2.15 | 1.01 | 3.29 | 3.38 |
| Borrowings | 2.55 | 5.94 | 0 | 1.05 | 0 |
| Other Liabilities | 1.12 | 0.08 | 0.25 | 0.51 | 1.31 |
| Total Liabilities | 5.92 | 8.18 | 5.72 | 10.92 | 10.76 |
| Fixed Assets | 4.91 | 6.38 | 1.3 | 1.57 | 4.55 |
| CWIP | 0 | 0 | 0 | 0 | 0 |
| Investments | 0 | 0 | 0 | 3.24 | 0.14 |
| Other Assets | 1.01 | 1.8 | 4.42 | 6.11 | 6.07 |
| Total Assets | 5.92 | 8.18 | 5.72 | 10.92 | 10.76 |

### Cash Flow

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- |
| Cash from Operating Activity | 1.11 | -0.95 | -3.31 | -0.62 | 1.3 |
| Cash from Investing Activity | -2.79 | -1.78 | -1.39 | -3.64 | -0.14 |
| Cash from Financing Activity | 1.63 | 2.86 | 4.77 | 4.38 | -1.09 |
| Net Cash Flow | -0.05 | 0.13 | 0.07 | 0.12 | 0.07 |
| Free Cash Flow | -1.77 | -2.83 | -4.7 | -4.26 | -1.98 |
| CFO/OP | 99 | -118 | -321 | -75 | 255 |

### Ratios

| Item | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- |
| Debtor Days | 2.15 | 24.07 | 43.35 | 70.19 | 55.45 |
| Inventory Days | 0 | 0 | — | 613.2 | 90.68 |
| Days Payable | — | — | — | 277.4 | 190.43 |
| Cash Conversion Cycle | 2.15 | 24.07 | 43.35 | 405.99 | -44.3 |
| Working Capital Days | -76.45 | 24.07 | 144.04 | 154.42 | 127.96 |
| ROCE % | — | 7.13 | 13.85 | 9.45 | 2.52 |

## Shareholding Pattern

### Quarterly

| Category | Dec 2023 | Sep 2024 | Mar 2025 | Sep 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- |
| Promoters | 86.74% | 63.76% | 63.76% | 63.76% | 63.86% |
| FIIs | 0% | 0% | 0% | 0% | 0% |
| DIIs | 0% | 0.1% | 0% | 0% | 0% |
| Government | 0% | 0% | 0% | 0% | 0% |
| Public | 0% | 31.99% | 33.77% | 33.87% | 34.95% |
| Others | 13.26% | 4.15% | 2.47% | 2.37% | 1.19% |
| No. of Shareholders | 10 | 207 | 202 | 200 | 183 |

## Technical Indicators

Derived from daily closing prices and recomputed each trading session; values move with the market.

- **Overall Signal:** Sell
- **Buy / Neutral / Sell:** 1 / 9 / 9

### Moving Averages — summary: **Strong Sell**

| Indicator | Value | Signal |
| --- | --- | --- |
| SMA (10) | 15.68 | Sell |
| EMA (10) | 16.22 | Sell |
| SMA (20) | 15.59 | Sell |
| EMA (20) | 15.9 | Sell |
| SMA (50) | 15.68 | Sell |
| EMA (50) | 16.38 | Sell |
| SMA (100) | 17.85 | Sell |
| EMA (100) | 18.51 | Sell |
| SMA (200) | — | Neutral |
| EMA (200) | — | Neutral |

### Oscillators — summary: **Neutral**

| Indicator | Value | Signal |
| --- | --- | --- |
| RSI (14) | 48.54 | Neutral |
| MACD (12,26,9) | 0.21 | Buy |
| Stochastic (14,3,3) | 67.11 | Neutral |
| ADX (14) | 12.05 | Neutral |
| Williams %R (14) | -60.96 | Neutral |
| ATR (14) | 1.73 | High Volatility |
| ROC (12) | -3 | Sell |
| Stoch RSI (14) | 39.79 | Neutral |
| UO (7,14,28) | 58.74 | Neutral |

## Filings & Documents

### Other Documents

| Date | Document |
| --- | --- |
| 7m - Appointment of Mrs Sindhu Suneer Kotian as Independent Director, term Mar 07, 2026–Mar 06, 2031, shareholder approval pending. | [Announcement under Regulation 30 (LODR)-Change in Management 7m - Appointment of Mrs Sindhu Suneer Kotian as Independent Director, term Mar 07, 2026–Mar 06, 2031, shareholder approval pending.](https://www.bseindia.com/xml-data/corpfiling/AttachLive/007de756-b281-4ba2-8575-e8090856c68d.pdf) |
| 30 Apr - Company declares non-applicability of Large Corporate criteria for FY ended 31 March 2026. | [Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A 30 Apr - Company declares non-applicability of Large Corporate criteria for FY ended 31 March 2026.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/ab0603cf-2bc4-42cb-8445-c7ccc57de502.pdf) |
| 30 Apr - Company declares non-applicability of Large Corporate criteria for FY ended 31 March 2026. | [Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A 30 Apr - Company declares non-applicability of Large Corporate criteria for FY ended 31 March 2026.](https://www.bseindia.com/xml-data/corpfiling/AttachLive/ab0603cf-2bc4-42cb-8445-c7ccc57de502.pdf) |
| 24 Feb - Of Newspaper Publication of Rights Issue of Equity Shares. | [Announcement under Regulation 30 (LODR)-Newspaper Publication 24 Feb - Of Newspaper Publication of Rights Issue of Equity Shares.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/0d127328-d54b-4b5b-b0c1-9a4fb9f9407e.pdf) |
| 19 Mar - Certificate under reg. 74(5) of SEBI (DP) Regulations, 2018 for the Quarter Ended on December 31, 2025. | [Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 19 Mar - Certificate under reg. 74(5) of SEBI (DP) Regulations, 2018 for the Quarter Ended on December 31, 2025.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/d2d266b1-8495-4434-a69e-10d71cfffce5.pdf) |
| 14 Nov 2025 - Unaudited standalone results for half year ended Sep 30, 2025 with limited review report filed. | [Unaudited Standalone Financial Results For The Half Year Ended September 30, 2025 Along With The Limited Review Report. 14 Nov 2025 - Unaudited standalone results for half year ended Sep 30, 2025 with limited review report filed.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/0dc5c639-79d2-427c-8d37-8d742cd396fe.pdf) |
| 14 Nov 2025 - Unaudited standalone results for half year ended 30 Sep 2025; limited review report submitted 14 Nov 2025. | [Intimation Of Unaudited Standalone Financial Results For The Half Year Ended September 30, 2025 Along With The Limited Review Report 14 Nov 2025 - Unaudited standalone results for half year ended 30 Sep 2025; limited review report submitted 14 Nov 2025.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/ed2af990-f8f1-42ef-a4df-457bc9534834.pdf) |
| 14 Nov 2025 - IPO funds deviation statement filed as on Sep 30, 2025 for Broach Lifecare (Scrip 544231) | [Statement Of Deviation(S) Or Variation(S) Of Funds Raised Through Public Issue 14 Nov 2025 - IPO funds deviation statement filed as on Sep 30, 2025 for Broach Lifecare (Scrip 544231)](https://www.bseindia.com/xml-data/corpfiling/AttachHis/85af7f87-3b61-4461-977c-580902a19bb6.pdf) |
| 14 Nov 2025 - Board appointed M/s. R. M. Hariyani & Co. as internal auditor for FY2025-26 on November 14, 2025. | [Intimation For Appointment Of Internal Auditor For FY 2025-26 14 Nov 2025 - Board appointed M/s. R. M. Hariyani & Co. as internal auditor for FY2025-26 on November 14, 2025.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/f97a334b-d02d-4f44-baa2-9d74ac21a416.pdf) |
| 14 Nov 2025 - Appointed N R Shah and Co as Secretarial Auditor for FY2025-26 on 14 November 2025. | [Intimation For Appointment Of Secretarial Auditor For The FY 2025-26 14 Nov 2025 - Appointed N R Shah and Co as Secretarial Auditor for FY2025-26 on 14 November 2025.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/4453cd9a-cc23-4a36-bab4-241fe99cd4a7.pdf) |

### Exchange Filings & Announcements

| Date | Document |
| --- | --- |
| 2026-09-09 | [Announcement under Regulation 30 (LODR)-Newspaper Publication](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=260a7c82-5bb5-445f-8713-8c4b19320dde.pdf) |
| 2026-09-09 | [Disclosure Under Regulation 30 And 36(1)(B) Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 (Listing Regulations).](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7d2a33b3-d812-4b31-a917-34adbe9fc451.pdf) |
| 2026-09-08 | [Notice Of 3Rd Annual General Meeting And E-Voting Facility](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=6c477eb8-3891-4e94-a636-160c4bf04525.pdf) |
| 2026-09-08 | [Reg. 34 (1) Annual Report.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=31c87010-f152-4088-9b05-6fece8407d57.pdf) |
| 2026-09-05 | [Board Meeting Outcome for Outcome Of Board Meeting Held On Saturday September 5 2026](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7083f5d2-dbc4-469d-b336-67549b9c9f99.pdf) |
| 2026-09-05 | [Announcement under Regulation 30 (LODR)-Change in Management](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c8eca9e0-3dc7-4535-bf36-720aa6f58a52.pdf) |
| 2026-08-31 | [Announcement under Regulation 30 (LODR)-Resignation of Company Secretary / Compliance Officer](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=cce8d7dd-0f33-4d87-a7e4-f374ecebd7ac.pdf) |
| 2026-08-31 | [Board Meeting Intimation for Intimation Of Board Meeting To Be Held On Saturday September 5 2026](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=17c4a3df-a52d-4fec-91d8-adbaa79df78b.pdf) |
| 2026-08-31 | [Board Meeting Intimation for Intimation Of Board Meeting To Be Held On Saturday September 5 2026](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ac5c6bcf-c652-49bc-9082-c6910a28392c.pdf) |
| 2026-08-26 | [Board Meeting Outcome for Outcome Of Board Meeting Held On August 26 2026.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=3ced6e6c-b181-4e94-8772-c607223df3c2.pdf) |

### Results & Financial Statements

| Date | Document |
| --- | --- |
| 2026-05-21 | [Submission Of Audited Standalone Financial Results Of The Company Along With The AuditorS Report For The Half Year And Year Ended March 31 2026.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=41198a5a-766e-4692-9d4a-20c704410faf.pdf) |
| 2025-11-14 | [Unaudited Standalone Financial Results For The Half Year Ended September 30 2025 Along With The Limited Review Report.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=0dc5c639-79d2-427c-8d37-8d742cd396fe.pdf) |
| 2025-05-30 | [Submission Of Audited Standalone Financial Results Of The Company Along With The AuditorS Report For The Half Year And Year Ended March 31 2025.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=feaa667c-6d16-436c-8877-3bfe918e081c.pdf) |
| 2024-11-14 | [Results- Financial Results For September 30, 2024](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d21ae911-8844-45f6-82d3-c1f0bd51604d.pdf) |

### Annual Reports

| Date | Document |
| --- | --- |
| from bse | [Annual Report 2025 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/7e0caca3-602f-4515-8078-658772bf4dcc.pdf) |
| from bse | [Financial Year 2025 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/d72bb892-2696-49cc-9f12-396581fa4f37.pdf) |
| from bse | [Financial Year 2024 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/c588b6e8-de10-428d-bd86-681978023444.pdf) |
| from bse | [Financial Year 2023 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/bf10c6b6-bb72-452a-a0d0-7dc08a9111b7.pdf) |
| from bse | [Financial Year 2022 from bse](https://www.bseindia.com/bseplus/AnnualReport/506642/75421506642_20_09_22.pdf) |
| from bse | [Financial Year 2021 from bse](https://www.bseindia.com/bseplus/AnnualReport/506642/71515506642.pdf) |
| from bse | [Financial Year 2020 from bse](https://www.bseindia.com/bseplus/AnnualReport/506642/65789506642.pdf) |
| from bse | [Financial Year 2019 from bse](https://www.bseindia.com/bseplus/AnnualReport/506642/5066420319.pdf) |
| from bse | [Financial Year 2018 from bse](https://www.bseindia.com/bseplus/AnnualReport/506642/5066420318.pdf) |
| from bse | [Financial Year 2017 from bse](https://www.bseindia.com/bseplus/AnnualReport/506642/5066420317.pdf) |

### Earnings Call Documents

| Date | Document |
| --- | --- |
| Nov 2023 | [Concall - Nov 2023](https://www.bseindia.com/xml-data/corpfiling/AttachHis/f3834cb9-88d0-4832-9bda-9a8ee90a0d2a.pdf) |
| Nov 2018 | [Concall - Nov 2018](https://www.bseindia.com/xml-data/corpfiling/CorpAttachment/2018/11/8f49c5f4-cc92-45d3-b23c-a24020daa6e1.pdf) |
| Jun 2024 | [Concall - Jun 2024](https://www.bseindia.com/xml-data/corpfiling/AttachHis/4f70c831-2f97-43f6-892e-66b2c0b44917.pdf) |
| Jun 2019 | [Concall - Jun 2019](https://www.bseindia.com/xml-data/corpfiling/AttachHis/180801fd-9233-444a-86eb-3b4396406fb9.pdf) |
| Feb 2024 | [Concall - Feb 2024](https://www.bseindia.com/xml-data/corpfiling/AttachHis/3d2aa7c1-a304-44b7-b1a9-a43956f320ed.pdf) |
| Feb 2024 | [Concall - Feb 2024](https://www.bseindia.com/xml-data/corpfiling/AttachHis/d85d2c40-7f41-4c05-8ad9-0c32a1b923cd.pdf) |

---

Provenance differs by section. Financial statements, shareholding and filings are as reported in company disclosures to NSE/BSE/SEBI. Price, volume and 52-week levels are exchange market data. Technical indicators are computed by Tapetide from daily closing prices. The Tapetide Score is Tapetide's own analysis. Analyst ratings are third-party estimates, not company statements. All figures are for research and information only and are not investment advice. Generated 2026-09-13T18:26:45.203Z.